These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36930514)

  • 1. Inflammatory rheumatic diseases developed after COVID-19 vaccination: presentation of a case series and review of the literature.
    Akkuzu G; Bes C; Özgür DS; Karaalioğlu B; Mutlu MY; Yıldırım F; Atagündüz P; Gündüz A; Soy M
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2143-2151. PubMed ID: 36930514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is vaccination against COVID-19 associated with autoimmune rheumatic disease flare? A self-controlled case series analysis.
    Nakafero G; Grainge MJ; Card T; Mallen CD; Nguyen Van-Tam JS; Williams HC; Abhishek A
    Rheumatology (Oxford); 2023 Apr; 62(4):1445-1450. PubMed ID: 36048896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic Granulomatosis With Polyangiitis Following COVID-19 Vaccination: A Case Report.
    Hwang YK; Kwak HH; Yun JE; Kim SH; Chang YS
    J Korean Med Sci; 2023 Dec; 38(48):e382. PubMed ID: 38084026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series.
    Furer V; Zisman D; Kibari A; Rimar D; Paran Y; Elkayam O
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI90-SI95. PubMed ID: 33848321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey.
    Gaur P; Agrawat H; Shukla A
    Rheumatol Int; 2021 Sep; 41(9):1601-1605. PubMed ID: 34213580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunogenicity of seasonal and pandemic influenza vaccination in autoimmune inflammatory rheumatic patients-a 6-month follow-up prospective study.
    Lakota K; Perdan-Pirkmajer K; Sodin-Šemrl S; Čučnik S; Šubelj V; Prosenc K; Mrak Poljšak K; Tomšič M; Ambrožič A; Praprotnik S
    Clin Rheumatol; 2019 May; 38(5):1277-1292. PubMed ID: 30761436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong.
    Li X; Gao L; Tong X; Chan VKY; Chui CSL; Lai FTT; Wong CKH; Wan EYF; Chan EWY; Lau KK; Lau CS; Wong ICK
    J Autoimmun; 2022 Jun; 130():102830. PubMed ID: 35461018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.
    Frommert LM; Arumahandi de Silva AN; Zernicke J; Scholz V; Braun T; Jeworowski LM; Schwarz T; Tober-Lau P; Ten Hagen A; Habermann E; Kurth F; Sander LE; Corman VM; Burmester GR; Biesen R; Albach FN; Klotsche J
    RMD Open; 2022 Dec; 8(2):. PubMed ID: 36597977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non- to low-responders and B cell deficient rheumatic disease patients.
    Ten Hagen A; Hermann S; Habermann E; Frommert LM; Arumahandi de Silva AN; Scholz V; Ghannam K; Klotsche J; Zernicke J; Alexander T; Burmester GR; Albach FN; Biesen R
    J Autoimmun; 2023 Feb; 135():102996. PubMed ID: 36642057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 infection and efficacy of vaccination in patients with rheumatic diseases during Omicron outbreak in South Korea: a prospective cohort study.
    Kim YK; Kim JY; Jung JI; Park JK; Lee EY; Lee EB; Park JW
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 37973535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.
    Perdan-Pirkmajer K; Thallinger GG; Snoj N; Čučnik S; Žigon P; Kveder T; Logar D; Praprotnik S; Tomšič M; Sodin-Semrl S; Ambrožič A
    Lupus; 2012 Feb; 21(2):175-83. PubMed ID: 22235050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covid-19 vaccination in autoimmune rheumatic diseases: A multi-center survey from southern India.
    Mohanasundaram K; Santhanam S; Natarajan R; Murugesan H; Nambi T; Chilikuri B; Nallasivan S
    Int J Rheum Dis; 2022 Sep; 25(9):1046-1052. PubMed ID: 35773944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis.
    Naveen R; Parodis I; Joshi M; Sen P; Lindblom J; Agarwal V; Lilleker JB; Tan AL; Nune A; Shinjo SK; Salim B; Ziade N; Velikova T; Edgar Gracia-Ramos A; Saavedra MA; Day J; Makol A; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L; Nikiphorou E;
    Rheumatology (Oxford); 2023 Jul; 62(7):2366-2376. PubMed ID: 36315075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination.
    Šinkovec Savšek T; Zajc Avramovič M; Avčin T; Korva M; Avšič Županc T; Toplak N
    Pediatr Rheumatol Online J; 2023 May; 21(1):46. PubMed ID: 37208721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New-onset of rheumatic diseases following COVID-19 vaccination: the report of three cases and a literature review.
    Matsuda M; Funakubo Asanuma Y; Emoto K; Sakai S; Okumura N; Yazawa H; Maruyama T; Tsuzuki Wada T; Yokota K; Araki Y; Akiyama Y; Mimura T
    Immunol Med; 2024 Sep; 47(3):205-216. PubMed ID: 38627989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-onset inflammatory arthritis after COVID-19 vaccination: A systematic review.
    Chen CC; Chen CJ
    Int J Rheum Dis; 2023 Feb; 26(2):267-277. PubMed ID: 36371629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune inflammatory rheumatic diseases post-COVID-19 vaccination.
    Safary A; Esalatmanesh K; Eftekharsadat AT; Jafari Nakjavani MR; Khabbazi A
    Int Immunopharmacol; 2022 Sep; 110():109061. PubMed ID: 35978510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
    Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
    Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature review.
    Sagy I; Zeller L; Raviv Y; Porges T; Bieber A; Abu-Shakra M
    Rheumatol Int; 2022 Dec; 42(12):2261-2266. PubMed ID: 36098769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.